Second Sight Medical Products, Inc. (NASDAQ:EYES) is expected to announce second quarter financial results after market close (confirmed) on August 08, 2017. The company added about 0.8% percent in value since last earnings when it was at $1.27. Based on the most relevant historical data, there is a 88 percent probability for share price to go down following the next earnings report. Looking further into earnings reaction history, the stock had moved down 8 times out of last 9 quarters. It has topped earnings-per-share estimates 10% of the time in its last 12 earnings reports. It missed earnings on 2 occasions, and it has met expectations 2 time.
Second Sight Medical Products, Inc. (NASDAQ:EYES) Earnings Reaction History
Overall, the average earnings surprise was -33.45 percent over the past four quarters. It posted earnings per share at $-0.16 which missed the consensus $-0.14 projection (Negative surprise of -14.30%). Revenue came in at $1.01M versus consensus estimate of $1.32M. The stock dropped -6.30% percent the day following the earnings was released, and on 7th day price change was -6.30% percent.
On March 09, 2017, it posted earnings per share at $-0.24 versus the consensus estimate of $-0.17 (Negative surprise of -41.20%). Revenue of $0.71M was below the $1.76M analysts had expected. The stock dropped -7.10% the day following the earnings was released, and on 7th day price change was -21.94%.
On November 02, 2016, it posted earnings per share at $-0.2, missed the consensus estimate of $-0.16 (Negative surprise of -25.00%). Revenue for the quarter was $1.18M while analysts had expected revenues to come in at $2.36M. The stock fell -13.91% the day following the earnings was released, and on 7th day price change was -4.61%.
On July 28, 2016, it posted earnings per share at $-0.23 compared with the consensus estimate of $-0.15 (Negative surprise of -53.30%). That came on revenues of $1.04M for the quarter. Analysts had expected $1.38M in revenue.
Second Sight Medical Products, Inc. (NASDAQ:EYES) Earnings Expectations
In front of Q3 earnings release, Wall Street is expecting earnings per share of $-0.15. The analysts’ current consensus range is $-0.15-$-0.15 for EPS. The market consensus range for revenue is $1.43M-$1.43M, with an average of $1.43M.
Second Sight Medical Products, Inc. (NASDAQ:EYES) last closed at $1.27, sending the company’s market cap around $72.67M. The consensus 12-month price target from brokerage firms covering the stock is $5.00 . The share price has declined -72.09% from its best level in 52 weeks and advanced -35.53% this year. It recently traded in a range of $1.25-$1.46 at a volume of 1,802,863 shares. The stock ended last trading session with the price nearly -3.05% lower for the last 5 trading days, rebounding 19.81% from its 52-week low.